Washington, USA
+919405476170
+919405476170

Relidomide 10mg Capsule Supplier USA | Pharmaceutical Exporter from India

Relidomide 10mg Capsule: Vital Immunomodulatory Therapy for Hematology



Are you searching for a dependable Relidomide 10 mg capsule exporter from IndiaErnest Oncology, a dedicated division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of high-quality oncology medications. We provide a specialized, regulatory-compliant supply chain to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that critical hematological treatments reach healthcare providers with maximum efficiency and pharmaceutical-grade integrity. 





Detailed Product Overview: What is Relidomide 10mg?


Relidomide 10 mg is an oral antineoplastic medication containing the active ingredient Lenalidomide. It is a cornerstone of Immunomodulatory Imide (IMiD) therapy. As a potent analogue of thalidomide, Relidomide was developed to enhance anti-cancer activity while improving the safety profile, specifically targeting the microenvironment of bone marrow-related cancers.

The 10mg strength is a versatile dosage used across multiple clinical stages, including:


  • Initial Combination Therapy: Used alongside other agents to induce remission.

  • Maintenance Therapy: The primary strength used for long-term stabilization in Multiple Myeloma patients after stem cell transplants.

  • Renal Adjustment: A critical dosage for patients requiring lower concentrations due to impaired kidney function.




Primary Therapeutic Indications: 


Relidomide 10 mg is clinically indicated for the following:  

  • Multiple Myeloma (MM): For patients who have received at least one prior therapy or as maintenance treatment following autologous stem cell transplantation.

  • Myelodysplastic Syndromes (MDS): For transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

  • Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.

  • Follicular & Marginal Zone Lymphoma: In combination with rituximab for previously treated patients.





Mechanism of Action: How Relidomide 10 mg Works: 


Relidomide 10mg utilizes a multi-targeted biological approach to treat cancer:

  1. Direct Anti-Tumor Effect: It binds to cereblon, an E3 ubiquitin ligase, triggering the degradation of transcription factors essential for the survival of malignant B-cells.

  2. Anti-Angiogenesis: It inhibits the growth of new blood vessels (angiogenesis) within the tumor, cutting off the supply of oxygen and nutrients.

  3. Immune System Modulation: It stimulates the patient’s own Natural Killer (NK) cells and T-cells, enhancing the body’s ability to recognize and destroy cancer cells.

  4. Microenvironment Alteration: It reduces the production of pro-inflammatory cytokines that otherwise foster a supportive environment for tumor cells in the bone marrow.




Clinical Administration & Safety:


  • Dosage: Taken orally once daily, typically in 21-day cycles followed by a 7-day break.

  • Administration: Must be swallowed whole at the same time each day; do not open, chew, or crush.

  • Pregnancy Warning: Embryo-Fetal Toxicity. Relidomide can cause severe, life-threatening birth defects. Access is strictly controlled via REMS programs worldwide.

  • Blood Monitoring: Patients must undergo regular blood tests to monitor for neutropenia (low white cells) and thrombocytopenia (low platelets).





Why Source Relidomide 10 mg from Ernest Oncology?


  • Verified Exporter from India: Direct sourcing from GMP-certified facilities ensures 100% authenticity and competitive B2B pricing.

  • Global Logistics Authority: Expert handling of pharmaceutical exports to the USA, UK, UAE, Australia, and South Africa. 

  • Bulk Inventory Stability: Consistent supply of all strengths (5 mg, 10 mg, 15 mg, 25 mg) to ensure zero interruptions in patient care.

  • Documentation & Compliance: We provide full documentation support, including COAs and necessary export permits for seamless customs clearance.


📞 Contact Ernest Oncology — Pharmaceutical Exporter from India

                [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

 2026-03-31T08:00:20

Keywords